Tonix Pharmaceuticals Holding Corp (TNXP): Next-Year EPS Estimate 33.87%
As of 2026-06-11, Tonix Pharmaceuticals Holding Corp (TNXP) has a next-year EPS growth estimate of 33.87%.
On 2026-05-26, analyst consensus for TNXP's next-year EPS growth shifted from 33.79% to 33.87% — a positive change of 0.08 percentage points. The revised estimate has been sustained across 13 subsequent trading sessions. Current-year growth is projected at 31.85%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 33.87%
- EPS growth this year
- 31.85%
- EPS next quarter (est)
- -$2.55
- Last price
- $10.65
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 33.87% | 31.85% | -$2.55 | $10.65 |
| 2026-06-10 | 33.87% | 31.85% | -$2.55 | $10.96 |
| 2026-06-09 | 33.87% | 31.85% | -$2.55 | $11.46 |
| 2026-06-08 | 33.87% | 31.85% | -$2.55 | $11.71 |
| 2026-06-07 | 33.87% | 31.85% | -$2.55 | $11.07 |
| 2026-06-04 | 33.87% | 31.85% | -$2.55 | $11.88 |
| 2026-06-03 | 33.87% | 31.85% | -$2.55 | $11.40 |
| 2026-06-02 | 33.87% | 31.85% | -$2.55 | $11.72 |
| 2026-06-01 | 33.87% | 31.85% | -$2.55 | $12.29 |
| 2026-05-31 | 33.87% | 31.85% | -$2.55 | $12.33 |
| 2026-05-28 | 33.87% | 31.85% | -$2.55 | $12.64 |
| 2026-05-27 | 33.87% | 31.85% | -$2.55 | $12.15 |
| 2026-05-26 | 33.87% | 31.85% | -$2.55 | $12.77 |
| 2026-05-25 | 33.79% | 31.93% | -$2.55 | $12.77 |
| 2026-05-24 | 33.79% | 31.93% | -$2.55 | $12.77 |
| 2026-05-21 | 33.79% | 31.93% | -$2.55 | $14.00 |
| 2026-05-20 | 34.67% | 32.41% | -$2.52 | $14.50 |
| 2026-05-19 | 34.67% | 32.41% | -$2.52 | $13.71 |
| 2026-05-18 | 34.67% | 32.41% | -$2.52 | $14.26 |
| 2026-05-17 | 35.52% | 32.41% | -$2.52 | $15.74 |
| 2026-05-14 | 35.52% | 32.41% | -$2.52 | $14.09 |
| 2026-05-13 | 35.52% | 32.41% | -$2.52 | $13.77 |
| 2026-05-12 | 35.52% | 32.41% | -$2.52 | $13.28 |
| 2026-05-11 | 32.88% | 34.73% | -$2.57 | $14.11 |
| 2026-05-10 | 32.88% | 34.73% | -$2.57 | $14.09 |
| 2026-05-07 | 32.88% | 34.73% | -$2.57 | $13.62 |
| 2026-05-06 | 32.88% | 34.73% | -$2.57 | $14.69 |
| 2026-05-05 | 32.88% | 34.73% | -$2.57 | $13.50 |
| 2026-05-04 | 32.88% | 34.73% | -$2.57 | $13.03 |
| 2026-05-03 | 49.89% | 35.28% | -$2.48 | $13.60 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Tonix Pharmaceuticals Holding Corp's next-year EPS growth estimate?▾
As of 2026-06-11, Tonix Pharmaceuticals Holding Corp (TNXP) has a next-year EPS growth estimate of 33.87%, based on analyst consensus.
When was the latest EPS estimate revision for TNXP?▾
The most recent revision occurred on 2026-05-26, when analysts adjusted the next-year EPS growth estimate from 33.79% to 33.87%.
What sector and industry does Tonix Pharmaceuticals Holding Corp belong to?▾
Tonix Pharmaceuticals Holding Corp operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TNXP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Tonix Pharmaceuticals Holding Corp (TNXP) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports